推薦產品
產品名稱
CL 316,243 水合物, ≥98% (HPLC), powder
品質等級
化驗
≥98% (HPLC)
形狀
powder
顏色
white to beige
溶解度
H2O: 10 mg/mL, clear
起源
Wyeth
儲存溫度
room temp
SMILES 字串
O.[Na+].[Na+].C[C@H](Cc1ccc2OC(Oc2c1)(C([O-])=O)C([O-])=O)NC[C@H](O)c3cccc(Cl)c3
InChI
1S/C20H20ClNO7.2Na.H2O/c1-11(22-10-15(23)13-3-2-4-14(21)9-13)7-12-5-6-16-17(8-12)29-20(28-16,18(24)25)19(26)27;;;/h2-6,8-9,11,15,22-23H,7,10H2,1H3,(H,24,25)(H,26,27);;;1H2/q;2*+1;/p-2/t11-,15+;;;/m1.../s1
InChI 密鑰
BFEWLXURNRQQLY-BELDDISZSA-L
基因資訊
human ... ADRB3(155)
尋找類似的產品? 前往 產品比較指南
應用
CL 316,243 水合物可用于:
- 作为β-激动剂,用于小鼠注射,研究其对哺乳动物主要促进子超家族结构域表达的影响-包含蛋白 (Mfsd2a)
- 作为肾上腺素能激动剂来刺激肾上腺素能反应,研究小鼠棕色、米色和白色脂肪组织的代谢活性
- 作为 β3-肾上腺素能激动剂,用于体内 注射脂解性挑战
生化/生理作用
β 肾上腺素能受体可以在许多组织中表达,例如心脏、脂肪组织、结肠和其他组织。它与多种不同的生物学功能有关。 β 肾上腺素能受体可以作为治疗2型糖尿病、心力衰竭、恶病质、肥胖、代谢紊乱,以及与膀胱、结肠和恶性肿瘤生长有关问题的靶向。抑郁和焦虑也可以利用β肾上腺素受体治疗。CL 316,243通过β肾上腺素能受体可以具有抗糖尿病作用。它是强力的脂肪分解刺激剂,还能激活 β下丘脑区域神经元上的12-3-肾上腺素受体,对食欲的中枢调节很重要。
CL 316,243是一种β3 肾上腺素受体激动剂和减肥药。
儲存類別代碼
11 - Combustible Solids
水污染物質分類(WGK)
WGK 3
閃點(°F)
Not applicable
閃點(°C)
Not applicable
個人防護裝備
Eyeshields, Gloves, type N95 (US)
客戶也查看了
Diabetes, 59(3), 686-693 (2009-12-05)
Type 2 diabetes increases breast cancer risk and mortality, and hyperinsulinemia has been identified as a major factor linking these two diseases. Thus, we hypothesized that pharmacological reduction of elevated insulin levels would attenuate type 2 diabetes-mediated mammary tumor progression.
British journal of pharmacology, 126(3), 819-825 (1999-04-03)
The possible existence of a beta3-adrenergic receptor (beta3-AR) in the human detrusor muscle was investigated by in vitro functional studies and analysis of mRNA expression. Isoprenaline, noradrenaline and adrenaline each produced a concentration-dependent relaxation of the human detrusor. The rank
Metabolic activity of brown,?beige,? and white adipose tissues in response to chronic adrenergic stimulation in male mice
American Journal of Physiology. Endocrinology and Metabolism, 311(1), E260-E268 (2016)
Proteomics, 9(22), 5067-5077 (2009-11-19)
Most phosphoproteomic studies to date have been limited to the identification of phosphoproteins and their phosphorylation sites, and have not assessed the stoichiometry of protein phosphorylation, a critical parameter reflecting the dynamic equilibrium between phosphorylated and non-phosphorylated pools of proteins.
Neurourology and urodynamics, 29(5), 771-776 (2009-10-10)
It has been suggested that beta(3)-adrenoceptor (beta(3)-AR) agonists affect not only the efferent but also the afferent pathways innervating the bladder. In addition, prostaglandin E(2) (PGE(2)) causes bladder hyperactivity in conscious rats. We investigated the direct effects of a beta(3)-AR
我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務